Women ages 50 to 64 reported the highest rate of GLP-1 use of any age group in a 2025 survey, with 20 percent saying they had used a GLP-1 drug at least once. While GLP-1s have been shown to treat obesity and type 2 diabetes and lower cardiometabolic risk, there’s emerging evidence that these drugs may help women in menopause in particular.
On average, menopause happens at age 52 in the United States and is marked by a major decline in ovarian production of estrogen and progesterone. Menopause brings about metabolic changes, which can affect how the body stores fat, as well as changes in heart health, sleep, joint health, and mood. Although…
Read the full article at EVERYDAYHEALTH.COM


